Knockdown of nuclear-retained long noncoding RNAs using modified DNA antisense oligonucleotides.

Long noncoding RNAs (lncRNAs) have recently emerged as important players in diverse cellular processes. Among them, a large fraction of lncRNAs are localized within cell nucleus. And several of these nuclear-retained lncRNAs have been found to regulate key nuclear processes, which brings up the requirement of effective genetic tools to explore the functions of this "dark matter" inside the nucleus. While siRNAs and shRNAs are widely used tools in loss-of-function studies, their general efficiency in depleting nuclear-retained lncRNAs is limited, due to the fact that the RNAi machinery is located mainly in the cytoplasm of mammalian cells. Here, we describe the usage of chemically modified chimeric DNA antisense oligonucleotides (ASO) in effective knockdown of nuclear-retained lncRNAs, with a focus on the detailed workflow from the design and synthesis of ASOs, to in vitro and in vivo delivery methods.

[1]  W. Filipowicz,et al.  Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Nakagawa,et al.  Nuclear lncRNAs as epigenetic regulators-beyond skepticism. , 2014, Biochimica et biophysica acta.

[3]  Yongjun Chu,et al.  RNAi Factors are Present and Active in Human Cell Nuclei , 2014, Cell reports.

[4]  S. Murray,et al.  Spinal distribution and metabolism of 2′-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats , 2005, Neuroscience.

[5]  Richard S Geary,et al.  Fomivirsen: clinical pharmacology and potential drug interactions. , 2002, Clinical pharmacokinetics.

[6]  T. P. Prakash,et al.  Synthesis and biophysical evaluation of 2',4'-constrained 2'O-methoxyethyl and 2',4'-constrained 2'O-ethyl nucleic acid analogues. , 2010, The Journal of organic chemistry.

[7]  Shuling Guo,et al.  Characterization of target mRNA reduction through in situ RNA hybridization in multiple organ systems following systemic antisense treatment in animals. , 2013, Nucleic acid therapeutics.

[8]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[9]  M. Manoharan,et al.  Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes , 2011, Nucleic acids research.

[10]  Takahide Yokoi,et al.  Efficient oligonucleotide-mediated degradation of nuclear noncoding RNAs in mammalian cultured cells. , 2009, RNA.

[11]  M. Gorospe,et al.  Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB , 2013, PLoS genetics.

[12]  B. Blencowe,et al.  The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. , 2010, Molecular cell.

[13]  Y. Hua,et al.  Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy , 2011, Science Translational Medicine.

[14]  P. Fraser,et al.  No-Nonsense Functions for Long Noncoding RNAs , 2011, Cell.

[15]  C. F. Bennett,et al.  Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents , 2003, The Journal of Biological Chemistry.

[16]  S. Crooke,et al.  Molecular mechanisms of action of antisense drugs. , 1999, Biochimica et biophysica acta.

[17]  Chaolin Zhang,et al.  The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. , 2012, Cell reports.

[18]  M. Hayden,et al.  Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS , 2013, Nucleic acids research.

[19]  B. Cullen,et al.  RNA interference in human cells is restricted to the cytoplasm. , 2002, RNA.

[20]  S. Crooke,et al.  Human RNase H1 Discriminates between Subtle Variations in the Structure of the Heteroduplex Substrate , 2007, Molecular Pharmacology.

[21]  Deepak K. Singh,et al.  Functional insights into the role of nuclear-retained long noncoding RNAs in gene expression control in mammalian cells , 2013, Chromosome Research.

[22]  K. Taira,et al.  Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. , 2003, Nucleic acids research.

[23]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[24]  T. Rana,et al.  Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. , 2004, Chemistry & biology.

[25]  B. Monia,et al.  Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice Published, JLR Papers in Press, January 22, 2007. , 2007, Journal of Lipid Research.